Abstract

Context

Abnormal maternal thyroid function in pregnancy may impair fetal brain development, but more evidence is needed to refine and corroborate the hypothesis.

Objective

To estimate the association between maternal thyroid function in early pregnancy and neuropsychological performance of the child at 5 years of age.

Design

Follow-up study.

Participants

A cohort of 1153 women and their children sampled from the Danish National Birth Cohort. Maternal thyroid-stimulating hormone (TSH) and free thyroxine (fT4) were measured in stored biobank sera from early pregnancy.

Main outcomes measures

Child neuropsychological test results (Wechsler Intelligence Scale/Test of Everyday Attention), test of motor function (Movement Assessment Battery), and results of parent and teacher reports (Behavior Rating Inventory of Executive Function/Strengths and Difficulties Questionnaire).

Results

Altogether 145 children (12.6%) were born to mothers with abnormal thyroid function in the early pregnancy. High maternal TSH and low fT4 were associated with lower child verbal intelligence quotient (adjusted mean difference TSH ≥ 10 mIU/L vs 0.1 to 2.49 mIU/L, −8.9 [95% confidence interval (CI), −15 to −2.4]; fT4 < 10 pmol/l vs 12.0 to 18.99 pmol/l, −13 [95% CI, −19 to −7.3]). Abnormal maternal thyroid function was also associated with adverse motor function and teacher-reported problems of executive function and behavior, and these associations were dominated by exposure to maternal hypothyroxinemia.

Conclusions

Maternal thyroid hormone abnormalities were associated with adverse neuropsychological function of the child at 5 years of age. For intelligence, marked hypothyroidism was important, whereas for motor function and executive and behavior problems, maternal hypothyroxinemia was predominant.

Thyroid hormones are important regulators of early brain development (1) and lack or excess of maternal thyroid hormone in early pregnancy may interfere and impair fetal brain development (2). Outcome of pregnancies prenatally exposed to maternal thyroid dysfunction is therefore a matter of concern. The potential benefits and risks associated with routine testing for undetected thyroid disease in pregnant women are debated (3), and the degree of thyroid abnormality relevant to screening and intervention remains unsolved (4). This study was conducted within the Danish National Birth Cohort (DNBC) to evaluate the association between maternal thyroid function as measured in stored biobank sera from early pregnancy and neuropsychological performance of children who at age 5 years participated in an extensive neuropsychological testing program. The program included testing of intelligence, attention, and motor function, as well as parent- and teacher-reported evaluation of executive function and behavior.

Methods and Materials

Study design and population

The DNBC enrolled about 100,000 pregnancies in 1997 to 2003 from women who lived in Denmark and were able to participate in telephone interviews in Danish during the pregnancy (5). For the investigation of maternal thyroid function in pregnancy within the DNBC, the woman’s first pregnancy in the study period was included if the woman completed the first of a series of telephone interviews in the pregnancy and gave birth to a singleton live-born child (Fig. 1).

Flowchart illustrating the eligible cohort of children and the number of children invited for follow-up and participating in neuropsychological assessment, as well as the number of children with available measurement of maternal thyroid function in early pregnancy.
Figure 1.

Flowchart illustrating the eligible cohort of children and the number of children invited for follow-up and participating in neuropsychological assessment, as well as the number of children with available measurement of maternal thyroid function in early pregnancy.

Participants for the current study were part of the Lifestyle During Pregnancy Study (LDPS), which is a subcohort within the DNBC (6). The LDPS sampled participants from maternal reports of alcohol intake and binge drinking in pregnancy, as described in detail elsewhere (6). In brief, the sampling procedure was based on the timing of exposure in pregnancy combined with information on the amount of alcohol intake (zero, one to four, five to eight, and nine or more drinks per week) and the number of binge episodes. Exclusion criteria were multiple pregnancies, inability to speak Danish well enough for participation, children with impaired hearing or vision likely to compromise the ability to complete the neuropsychological tests, and children with congenital disorders associated with mental retardation (e.g., Down syndrome and cerebral palsy) (6).

Among the singleton, live-born children eligible for the investigation of maternal thyroid function in pregnancy, a total of 3136 mother-child pairs were invited to participate in the LDPS when the child reached 5 years of age, and 1603 (51.1%) participated in the neuropsychological assessment (Fig. 1). At the time of enrollment in DNBC, a blood sample was drawn from the pregnant woman at the first antenatal visit in general practice (median, week 9 of pregnancy; range, week 5 to week 25; interquartile range, week 8 to week 11) (5). The blood sample was sent by mail and arrived in the Danish National Biobank within a median of 1 day from sampling, where it was stored in a −80°C freezer. Stored biobank sera for measurement of maternal thyroid function were available for 1153 (71.9%) of the 1603 mother-child pairs who participated in the follow-up assessment (Fig. 1).

All participating mothers had provided written informed consent at initial recruitment and during follow-up. The Danish Ethic Committee approved the study (N-20130054).

Exposure assessment

Maternal thyroid function was evaluated from measurement of thyroid-stimulating hormone (TSH) and free thyroxine (fT4) by a Dimension Vista automated immunoassay (Siemens Healthcare Diagnostics, Eschborn, Germany), as previously described (7, 8). The biochemical analyses were performed from January to August 2015. Maternal thyroid function was classified according to the method- and pregnancy week–specific reference ranges (2.5th and 97.5th percentiles) previously established and described for this cohort of women (7). In summary, week-specific reference ranges were used for pregnancy weeks 5 to 14, and a combined reference range for weeks 15 to 19 was applied to blood samples from week 15 and onward. Lower reference limit for TSH ranged from the highest value of 0.69 mIU/L (week 5) to the lowest value of 0.061 mIU/L (week 10), whereas the upper reference limit ranged from 3.09 (week 11) to 3.85 mIU/L (week 14). For fT4, less variation was observed and the lower reference limit ranged from 11.23 to 12.07 pmol/L, whereas the upper reference limit ranged from 17.60 to 19.16 pmol/L (7). The pregnant women were classified as having abnormal thyroid function if they had TSH and/or fT4 values below or above the week-specific reference limits, including overt hyperthyroidism or hypothyroidism defined by abnormal TSH and fT4, subclinical hyperthyroidism or hypothyroidism defined by abnormal TSH and normal fT4, or hyperthyroxinemia or hypothyroxinemia defined by abnormal fT4 with normal TSH (8).

Outcome assessment

Neuropsychological testing took place when the child was 60 to 64 months old in one of the four largest cities in Denmark from 2003 to 2008 (6). The testing was a 3-hour assessment and was performed by 10 trained psychologists who followed standardized test procedures; on a regular basis, these psychologists blindly scored several tests administered by other psychologists to calibrate agreement (6).

Intelligence was assessed by using a shorter version of the Wechsler Primary and Preschool Scale of Intelligence-Revised (WPPSI-R), including three verbal (arithmetic, information, and vocabulary) and three performance (block design, geometric design, and object assembly) subtests from which full, performance, and verbal intelligence quotients (IQs) were derived. Danish WPPSI-R norms were not available, and Swedish norms were used. Thus, the theoretical distribution of IQ with a mean of 100 and a standard deviation (SD) of 100 cannot be expected in this sample (9).

Attention was assessed by using the Test of Everyday Attention for Children at Five (TEACh-5), which has been described in detail elsewhere (10). TEACh-5 included four subtests: assessment of selective (the great balloon hunt and hide and seek II) and sustained (barking and draw a line) attention via visual and auditory stimuli. Each subscore was standardized to a mean of 0 and an SD of 1, and the mean of these was restandardized to a selective attention score and sustained attention score. Furthermore, an overall attention score was calculated as the mean of all four standardized subscores and restandardized.

Motor function was assessed from 2003 to 2006 on the same day as the neuropsychological testing and was performed by 30 physiotherapists who regularly compared and discussed their test procedures (6). Motor function was assessed by using the Movement Assessment Battery for Children (MABC), which included eight subtests covering fine and gross motor function and static and dynamic balance (11). A total score of 0 to 40 was calculated as the sum of all subtests, with a lower score indicating better performance. The total score was interpreted by using percentile norm tables, and children at or below the fifth percentile (total scores ranging from 17 to 40) were classified as having poor motor function (11).

Executive function and behavior of the child were assessed at home and in the daycare environment from questionnaires rated by the mother and a teacher. Executive function was assessed by using the Behavior Rating Inventory of Executive Function (BRIEF), which included 86 statements measuring eight aspects of executive function (12). Danish BRIEF norms were not available, and a normalizing T-score transformation for the observed scores was computed, with higher scores indicating more difficulties (13). The transformed scores were combined in the behavioral regulation index, including the scales for inhibit, shift, and emotional control, and a metacognition index, including the scales for initiate, working memory, plan/organize, organization of materials, and monitor. Furthermore, an overall global executive composite score was calculated as the mean of all eight scales. Behavior was assessed by using the Strengths and Difficulties Questionnaire (SDQ), which included 25 questions on five aspects of behavior (14). A total difficulties score was calculated as the mean of the four scales of emotional symptoms, peer problems, hyperactivity/inattention, and conduct problems, with higher scores indicating more difficulties. Furthermore, a score for internalizing problems (emotional and peer problems) and for externalizing problems (hyperactivity/inattention and conduct problems) were derived (15). The prosocial scale was not included in the current study because our focus was on problem behavior.

Covariates

Information on potential maternal and child covariates was obtained from the DNBC interviews during the pregnancy (maternal prepregnancy height and weight, smoking and alcohol intake in the pregnancy, and psychiatric disease), from the LDPS follow-up interview (parental education and marital status), and from the Danish Medical Birth Register (16) (child’s sex, 5-minutes Apgar score, gestational age at birth, and birth weight, as well as maternal age an parity). Information was also available on the age of the child at testing (1-month intervals from the age of 5 years) and on the testing psychologist.

Maternal intelligence was assessed at follow-up from two verbal subtests of the Wechsler Adult Intelligence Scale and from a nonverbal test of the Ravens’ Standard Progressive Matrices (13). Results from each subtest were weighted and equally standardized to a combined IQ (mean, 100; SD, 15).

Statistical analyses

The association between maternal thyroid function and child neuropsychological test results was evaluated by using linear and logistic regression. The main analyses were conducted with a combined categorical exposure variable of abnormal maternal thyroid function, defined as TSH and/or fT4 outside the pregnancy week–specific reference ranges (including overt and subclinical hyperthyroidism and hypothyroidism as well as hyperthyroxinemia and hypothyroxinemia). In subsequent analyses, we evaluated the association with different levels of TSH and fT4, separately, by using predefined cutoffs. Nonlinear associations were assessed by using restricted cubic splines with three knots (10th, 50th, and 90th percentiles) adjusting for pregnancy week of blood sampling.

Outcomes of WPPSI-R, TEACh-5, and BRIEF showed symmetric distribution, and results of linear regression were reported as mean difference with 95% confidence intervals (CIs). Outcomes of MABC and SDQ showed asymmetric distribution, and results were log-transformed and reported as exponentiated β values with 95% CIs. For outcomes of logistic regression, abnormal WPPSI-R and TEACh-5 results were defined as a score below the mean minus 1 SD, abnormal BRIEF as a score above the sample mean plus 1 SD, abnormal MABC as at or below the fifth percentile (11), and abnormal SDQ as a score above the sex-specific cutoffs previously established in Danish 5- to 7-year-old children (17).

The LDPS study oversampled women with a high alcohol intake during pregnancy, and analyses were weighted by sampling fraction with robust variance estimation to account for the sampling design (13). For outcomes of neuropsychological testing, child’s age at testing and testing psychologist were included in the model. Other potential confounders considered a priori were maternal IQ, age, parity, marital status, smoking and alcohol intake in pregnancy, prepregnancy body mass index (BMI), psychiatric disease, and parental education. We used the change-in-estimate method (10% cutoff) via backward elimination and identified maternal IQ and prepregnancy BMI for inclusion in the model. We observed no multicollinearity between maternal IQ and prepregnancy BMI. Results of this model strategy as compared with the fully adjusted model led to similar conclusions. We considered possible effect measure modification by child’s sex in stratified analyses and by measures of multiplicative (cross-product term) and additive (relative excess risk due to interaction) interaction. Missing values on maternal IQ (0.5%) and maternal prepregnancy BMI (2.4%) were imputed by using multiple imputation with chained equations and results of multiple imputation were reported. Complete case analysis was also performed and revealed similar results.

Statistical analyses were performed by using Stata software, version 13 (Stata Corp., College Station, TX).

Results

Altogether, 1153 children and their mothers had available data on child neuropsychological testing and data on maternal thyroid function and were included in the study. As expected, the children sampled for the follow-up study differed from the eligible cohort of live-born children in regard to maternal alcohol intake in pregnancy (Table 1). Besides that, few differences were found between children invited for follow-up, those who participated in follow-up, and children with measurement of maternal thyroid function (Table 1).

Table 1.

Characteristic of Eligible Cohort of Singleton Live-Born Children, Children Invited for Follow-Up, Children Who Participated in Follow-Up, and Children Who Participated in Follow-Up and Had Maternal Thyroid Function Tested in a Blood Sample From the Early Pregnancy

CharacteristicEligible CohortInvited for Follow-UpParticipated in Follow-UpMaternal Thyroid Function
Children (n)78,553313616031153
Birth year of the child
 1997–200046,980 (59.8)1583 (50.5)834 (52.0)572 (49.6)
 2001–200331,573 (40.2)1553 (49.5)769 (48.0)581 (50.4)
Child’s sex
 Female38,338 (48.8)1534 (48.9)777 (48.5)549 (47.6)
 Male40,215 (51.2)1602 (51.1)826 (51.5)604 (52.4)
Gestational age at birtha
 <37 wk4,147 (5.3)136 (4.3)49 (3.1)29 (2.5)
 ≥37 wk74,228 (94.7)2996 (95.7)1551 (96.9)1124 (97.5)
Birth weighta
 <2500 g2,438 (3.1)74 (2.4)24 (1.5)13 (1.1)
 ≥2500 g76,003 (96.9)3059 (97.6)1576 (98.5)1138 (98.9)
5-min Apgar scorea
 7–1077,362 (99.3)3107 (99.5)1582 (99.4)1137 (99.5)
 0–6564 (0.7)14 (0.5)9 (0.6)6 (0.5)
Maternal paritya
 Nulliparous38,097 (49.9)1636 (53.7)846 (54.6)606 (53.8)
 Multiparous38,264 (50.1)1412 (46.3)705 (45.4)520 (46.2)
Maternal age
 <30 y38,521 (49.0)1519 (48.4)731 (45.6)507 (44.0)
 ≥30 y40,032 (51.0)1617 (51.6)872 (54.4)646 (56.0)
Maternal prepregnancy BMIa,b
 <25 kg/m256,001 (72.5)2214 (71.8)1173 (74.8)837 (74.4)
 ≥25 kg/m221,207 (27.5)869 (28.2)396 (25.2)288 (25.6)
Maternal smoking in pregnancya,b
 Yes21,112 (26.9)1086 (34.7)523 (32.6)375 (32.5)
 No57,413 (73.1)2048 (65.3)1080 (67.4)778 (67.5)
Maternal alcohol intake in pregnancya,b
 0 units/wk43,687 (55.6)1559 (49.7)763 (47.6)539 (46.8)
 1–4 units/wk34,020 (43.3)1249 (39.8)663 (41.4)486 (42.1)
 ≥5 units/wk844 (1.1)328 (10.5)177 (11.0)128 (11.1)
CharacteristicEligible CohortInvited for Follow-UpParticipated in Follow-UpMaternal Thyroid Function
Children (n)78,553313616031153
Birth year of the child
 1997–200046,980 (59.8)1583 (50.5)834 (52.0)572 (49.6)
 2001–200331,573 (40.2)1553 (49.5)769 (48.0)581 (50.4)
Child’s sex
 Female38,338 (48.8)1534 (48.9)777 (48.5)549 (47.6)
 Male40,215 (51.2)1602 (51.1)826 (51.5)604 (52.4)
Gestational age at birtha
 <37 wk4,147 (5.3)136 (4.3)49 (3.1)29 (2.5)
 ≥37 wk74,228 (94.7)2996 (95.7)1551 (96.9)1124 (97.5)
Birth weighta
 <2500 g2,438 (3.1)74 (2.4)24 (1.5)13 (1.1)
 ≥2500 g76,003 (96.9)3059 (97.6)1576 (98.5)1138 (98.9)
5-min Apgar scorea
 7–1077,362 (99.3)3107 (99.5)1582 (99.4)1137 (99.5)
 0–6564 (0.7)14 (0.5)9 (0.6)6 (0.5)
Maternal paritya
 Nulliparous38,097 (49.9)1636 (53.7)846 (54.6)606 (53.8)
 Multiparous38,264 (50.1)1412 (46.3)705 (45.4)520 (46.2)
Maternal age
 <30 y38,521 (49.0)1519 (48.4)731 (45.6)507 (44.0)
 ≥30 y40,032 (51.0)1617 (51.6)872 (54.4)646 (56.0)
Maternal prepregnancy BMIa,b
 <25 kg/m256,001 (72.5)2214 (71.8)1173 (74.8)837 (74.4)
 ≥25 kg/m221,207 (27.5)869 (28.2)396 (25.2)288 (25.6)
Maternal smoking in pregnancya,b
 Yes21,112 (26.9)1086 (34.7)523 (32.6)375 (32.5)
 No57,413 (73.1)2048 (65.3)1080 (67.4)778 (67.5)
Maternal alcohol intake in pregnancya,b
 0 units/wk43,687 (55.6)1559 (49.7)763 (47.6)539 (46.8)
 1–4 units/wk34,020 (43.3)1249 (39.8)663 (41.4)486 (42.1)
 ≥5 units/wk844 (1.1)328 (10.5)177 (11.0)128 (11.1)

Numbers are n (%).

a

Individuals with missing values not included in the table.

b

Self-reported in the pregnancy.

Table 1.

Characteristic of Eligible Cohort of Singleton Live-Born Children, Children Invited for Follow-Up, Children Who Participated in Follow-Up, and Children Who Participated in Follow-Up and Had Maternal Thyroid Function Tested in a Blood Sample From the Early Pregnancy

CharacteristicEligible CohortInvited for Follow-UpParticipated in Follow-UpMaternal Thyroid Function
Children (n)78,553313616031153
Birth year of the child
 1997–200046,980 (59.8)1583 (50.5)834 (52.0)572 (49.6)
 2001–200331,573 (40.2)1553 (49.5)769 (48.0)581 (50.4)
Child’s sex
 Female38,338 (48.8)1534 (48.9)777 (48.5)549 (47.6)
 Male40,215 (51.2)1602 (51.1)826 (51.5)604 (52.4)
Gestational age at birtha
 <37 wk4,147 (5.3)136 (4.3)49 (3.1)29 (2.5)
 ≥37 wk74,228 (94.7)2996 (95.7)1551 (96.9)1124 (97.5)
Birth weighta
 <2500 g2,438 (3.1)74 (2.4)24 (1.5)13 (1.1)
 ≥2500 g76,003 (96.9)3059 (97.6)1576 (98.5)1138 (98.9)
5-min Apgar scorea
 7–1077,362 (99.3)3107 (99.5)1582 (99.4)1137 (99.5)
 0–6564 (0.7)14 (0.5)9 (0.6)6 (0.5)
Maternal paritya
 Nulliparous38,097 (49.9)1636 (53.7)846 (54.6)606 (53.8)
 Multiparous38,264 (50.1)1412 (46.3)705 (45.4)520 (46.2)
Maternal age
 <30 y38,521 (49.0)1519 (48.4)731 (45.6)507 (44.0)
 ≥30 y40,032 (51.0)1617 (51.6)872 (54.4)646 (56.0)
Maternal prepregnancy BMIa,b
 <25 kg/m256,001 (72.5)2214 (71.8)1173 (74.8)837 (74.4)
 ≥25 kg/m221,207 (27.5)869 (28.2)396 (25.2)288 (25.6)
Maternal smoking in pregnancya,b
 Yes21,112 (26.9)1086 (34.7)523 (32.6)375 (32.5)
 No57,413 (73.1)2048 (65.3)1080 (67.4)778 (67.5)
Maternal alcohol intake in pregnancya,b
 0 units/wk43,687 (55.6)1559 (49.7)763 (47.6)539 (46.8)
 1–4 units/wk34,020 (43.3)1249 (39.8)663 (41.4)486 (42.1)
 ≥5 units/wk844 (1.1)328 (10.5)177 (11.0)128 (11.1)
CharacteristicEligible CohortInvited for Follow-UpParticipated in Follow-UpMaternal Thyroid Function
Children (n)78,553313616031153
Birth year of the child
 1997–200046,980 (59.8)1583 (50.5)834 (52.0)572 (49.6)
 2001–200331,573 (40.2)1553 (49.5)769 (48.0)581 (50.4)
Child’s sex
 Female38,338 (48.8)1534 (48.9)777 (48.5)549 (47.6)
 Male40,215 (51.2)1602 (51.1)826 (51.5)604 (52.4)
Gestational age at birtha
 <37 wk4,147 (5.3)136 (4.3)49 (3.1)29 (2.5)
 ≥37 wk74,228 (94.7)2996 (95.7)1551 (96.9)1124 (97.5)
Birth weighta
 <2500 g2,438 (3.1)74 (2.4)24 (1.5)13 (1.1)
 ≥2500 g76,003 (96.9)3059 (97.6)1576 (98.5)1138 (98.9)
5-min Apgar scorea
 7–1077,362 (99.3)3107 (99.5)1582 (99.4)1137 (99.5)
 0–6564 (0.7)14 (0.5)9 (0.6)6 (0.5)
Maternal paritya
 Nulliparous38,097 (49.9)1636 (53.7)846 (54.6)606 (53.8)
 Multiparous38,264 (50.1)1412 (46.3)705 (45.4)520 (46.2)
Maternal age
 <30 y38,521 (49.0)1519 (48.4)731 (45.6)507 (44.0)
 ≥30 y40,032 (51.0)1617 (51.6)872 (54.4)646 (56.0)
Maternal prepregnancy BMIa,b
 <25 kg/m256,001 (72.5)2214 (71.8)1173 (74.8)837 (74.4)
 ≥25 kg/m221,207 (27.5)869 (28.2)396 (25.2)288 (25.6)
Maternal smoking in pregnancya,b
 Yes21,112 (26.9)1086 (34.7)523 (32.6)375 (32.5)
 No57,413 (73.1)2048 (65.3)1080 (67.4)778 (67.5)
Maternal alcohol intake in pregnancya,b
 0 units/wk43,687 (55.6)1559 (49.7)763 (47.6)539 (46.8)
 1–4 units/wk34,020 (43.3)1249 (39.8)663 (41.4)486 (42.1)
 ≥5 units/wk844 (1.1)328 (10.5)177 (11.0)128 (11.1)

Numbers are n (%).

a

Individuals with missing values not included in the table.

b

Self-reported in the pregnancy.

Altogether, 145 women (12.6%) had abnormal thyroid function in the early pregnancy blood sample (Table 2). A characteristic of children born to mothers with abnormal thyroid function was a lower maternal alcohol intake during the pregnancy and a lower educational level of the parents (Table 2). The subtypes of maternal thyroid dysfunction included overt hyperthyroidism (n = 8), subclinical hyperthyroidism (n = 16), overt hypothyroidism (n = 16), subclinical hypothyroidism (n = 35), hyperthyroxinemia (n = 11), and hypothyroxinemia (n = 59). Treatment with thyroid hormone in the early pregnancy was reported by four women, and thyroid function testing revealed normal results (n = 2), subclinical hyperthyroidism (n = 1), and isolated high fT4 (n = 1). None of the women reported use of antithyroid drugs.

Table 2.

Characteristics of Children Included in Study, Stratified by Maternal Thyroid Function in Early Pregnancy

CharacteristicNo Maternal Thyroid DysfunctionaMaternal Thyroid Dysfunctionb
Children (n)1,008145
Birth year of the child
 1997–2000503 (49.9)69 (47.6)
 2001–2003505 (50.1)76 (52.4)
Child’s sex
 Female475 (47.1)74 (51.0)
 Male533 (52.9)71 (49.0)
Gestational age at birth
 <37 wk25 (2.5)4 (2.8)
 ≥37 wk983 (97.5)141 (97.2)
Birth weightc
 <2500 g10 (1.0)3 (2.1)
 ≥2500 g996 (99.0)142 (97.9)
5-min Apgar scorec
 7–10992 (99.4)145 (100.0)
 0–66 (0.6)0 (0)
Maternal parityc
 Nulliparous533 (54.1)73 (52.1)
 Multiparous453 (45.9)67 (47.9)
Maternal age
 <30 y439 (43.6)68 (46.9)
 ≥30 y569 (56.4)77 (53.1)
Maternal prepregnancy BMIc,d
 <25 kg/m2741 (75.3)96 (68.1)
 ≥25 kg/m2243 (24.7)45 (31.9)
Maternal smoking in pregnancyc,d
 Yes329 (32.6)46 (31.7)
 No679 (67.4)99 (68.3)
Maternal alcohol intake in pregnancyd
 0 units/wk455 (45.1)84 (57.9)
 1-4 units/wk439 (43.6)47 (32.4)
 ≥5 units/wk114 (11.3)14 (9.7)
Maternal psychiatric diseased
 Yes102 (10.1)13 (9.0)
 No906 (89.9)132 (91.0)
Maternal IQe
 Abnormal low150 (14.9)29 (20.0)
 Normal858 (85.1)116 (80.0)
Parental educational levelc
 <12 y267 (26.7)51 (35.2)
 ≥12 y735 (73.3)94 (64.8)
CharacteristicNo Maternal Thyroid DysfunctionaMaternal Thyroid Dysfunctionb
Children (n)1,008145
Birth year of the child
 1997–2000503 (49.9)69 (47.6)
 2001–2003505 (50.1)76 (52.4)
Child’s sex
 Female475 (47.1)74 (51.0)
 Male533 (52.9)71 (49.0)
Gestational age at birth
 <37 wk25 (2.5)4 (2.8)
 ≥37 wk983 (97.5)141 (97.2)
Birth weightc
 <2500 g10 (1.0)3 (2.1)
 ≥2500 g996 (99.0)142 (97.9)
5-min Apgar scorec
 7–10992 (99.4)145 (100.0)
 0–66 (0.6)0 (0)
Maternal parityc
 Nulliparous533 (54.1)73 (52.1)
 Multiparous453 (45.9)67 (47.9)
Maternal age
 <30 y439 (43.6)68 (46.9)
 ≥30 y569 (56.4)77 (53.1)
Maternal prepregnancy BMIc,d
 <25 kg/m2741 (75.3)96 (68.1)
 ≥25 kg/m2243 (24.7)45 (31.9)
Maternal smoking in pregnancyc,d
 Yes329 (32.6)46 (31.7)
 No679 (67.4)99 (68.3)
Maternal alcohol intake in pregnancyd
 0 units/wk455 (45.1)84 (57.9)
 1-4 units/wk439 (43.6)47 (32.4)
 ≥5 units/wk114 (11.3)14 (9.7)
Maternal psychiatric diseased
 Yes102 (10.1)13 (9.0)
 No906 (89.9)132 (91.0)
Maternal IQe
 Abnormal low150 (14.9)29 (20.0)
 Normal858 (85.1)116 (80.0)
Parental educational levelc
 <12 y267 (26.7)51 (35.2)
 ≥12 y735 (73.3)94 (64.8)

Numbers are n (%).

a

TSH and fT4 between the pregnancy week–specific 2.5th and 97.5th percentiles.

b

TSH and/or fT4 outside the pregnancy week–specific 2.5th and 97.5th percentiles.

c

Individuals with missing values not included in the table.

d

Self-reported in the pregnancy.

e

Abnormal IQ defined by a score below the sample mean minus 1 SD.

Table 2.

Characteristics of Children Included in Study, Stratified by Maternal Thyroid Function in Early Pregnancy

CharacteristicNo Maternal Thyroid DysfunctionaMaternal Thyroid Dysfunctionb
Children (n)1,008145
Birth year of the child
 1997–2000503 (49.9)69 (47.6)
 2001–2003505 (50.1)76 (52.4)
Child’s sex
 Female475 (47.1)74 (51.0)
 Male533 (52.9)71 (49.0)
Gestational age at birth
 <37 wk25 (2.5)4 (2.8)
 ≥37 wk983 (97.5)141 (97.2)
Birth weightc
 <2500 g10 (1.0)3 (2.1)
 ≥2500 g996 (99.0)142 (97.9)
5-min Apgar scorec
 7–10992 (99.4)145 (100.0)
 0–66 (0.6)0 (0)
Maternal parityc
 Nulliparous533 (54.1)73 (52.1)
 Multiparous453 (45.9)67 (47.9)
Maternal age
 <30 y439 (43.6)68 (46.9)
 ≥30 y569 (56.4)77 (53.1)
Maternal prepregnancy BMIc,d
 <25 kg/m2741 (75.3)96 (68.1)
 ≥25 kg/m2243 (24.7)45 (31.9)
Maternal smoking in pregnancyc,d
 Yes329 (32.6)46 (31.7)
 No679 (67.4)99 (68.3)
Maternal alcohol intake in pregnancyd
 0 units/wk455 (45.1)84 (57.9)
 1-4 units/wk439 (43.6)47 (32.4)
 ≥5 units/wk114 (11.3)14 (9.7)
Maternal psychiatric diseased
 Yes102 (10.1)13 (9.0)
 No906 (89.9)132 (91.0)
Maternal IQe
 Abnormal low150 (14.9)29 (20.0)
 Normal858 (85.1)116 (80.0)
Parental educational levelc
 <12 y267 (26.7)51 (35.2)
 ≥12 y735 (73.3)94 (64.8)
CharacteristicNo Maternal Thyroid DysfunctionaMaternal Thyroid Dysfunctionb
Children (n)1,008145
Birth year of the child
 1997–2000503 (49.9)69 (47.6)
 2001–2003505 (50.1)76 (52.4)
Child’s sex
 Female475 (47.1)74 (51.0)
 Male533 (52.9)71 (49.0)
Gestational age at birth
 <37 wk25 (2.5)4 (2.8)
 ≥37 wk983 (97.5)141 (97.2)
Birth weightc
 <2500 g10 (1.0)3 (2.1)
 ≥2500 g996 (99.0)142 (97.9)
5-min Apgar scorec
 7–10992 (99.4)145 (100.0)
 0–66 (0.6)0 (0)
Maternal parityc
 Nulliparous533 (54.1)73 (52.1)
 Multiparous453 (45.9)67 (47.9)
Maternal age
 <30 y439 (43.6)68 (46.9)
 ≥30 y569 (56.4)77 (53.1)
Maternal prepregnancy BMIc,d
 <25 kg/m2741 (75.3)96 (68.1)
 ≥25 kg/m2243 (24.7)45 (31.9)
Maternal smoking in pregnancyc,d
 Yes329 (32.6)46 (31.7)
 No679 (67.4)99 (68.3)
Maternal alcohol intake in pregnancyd
 0 units/wk455 (45.1)84 (57.9)
 1-4 units/wk439 (43.6)47 (32.4)
 ≥5 units/wk114 (11.3)14 (9.7)
Maternal psychiatric diseased
 Yes102 (10.1)13 (9.0)
 No906 (89.9)132 (91.0)
Maternal IQe
 Abnormal low150 (14.9)29 (20.0)
 Normal858 (85.1)116 (80.0)
Parental educational levelc
 <12 y267 (26.7)51 (35.2)
 ≥12 y735 (73.3)94 (64.8)

Numbers are n (%).

a

TSH and fT4 between the pregnancy week–specific 2.5th and 97.5th percentiles.

b

TSH and/or fT4 outside the pregnancy week–specific 2.5th and 97.5th percentiles.

c

Individuals with missing values not included in the table.

d

Self-reported in the pregnancy.

e

Abnormal IQ defined by a score below the sample mean minus 1 SD.

Child intelligence was evaluated from full, performance, and verbal IQs (Table 3). For all measurements, mean IQ was lower in children born to mothers with thyroid dysfunction, but the mean difference attenuated in adjusted analyses (Table 3). Similarly, children born to mothers with thyroid dysfunction more frequently had abnormal low IQ, but adjustment for maternal BMI and IQ attenuated these associations (Table 3).When evaluated according to categories of TSH and fT4 (Fig. 2), a distinct pattern emerged from the association with verbal IQ. TSH of ≥ 10 mIU/L and fT4 < 10 pmol/L were associated with lower child IQ. No differences in verbal IQ were observed for maternal TSH < 0.1 mIU/L or in the range from 2.5 to 9.99 mIU/L. All women with fT4 < 10 pmol/L (Fig. 2) also had TSH ≥ 10 mIU/L and were classified as having overt hypothyroidism, whereas two of the six women with TSH ≥ 10 mIU/L had fT4 > 10 pmol/L and were classified as having overt and subclinical hypothyroidism. None of the six women with fT4 < 10 pmol/L and/or TSH ≥ 10 mIU/L reported current treatment with thyroid hormone, and the majority were subsequently diagnosed with thyroid disease during the pregnancy (n = 2) or after the pregnancy (n = 3). Among women with fT4 ranging from 10 to 12 pmol/L, 11 women were classified as having overt hypothyroidism (TSH ranging from 3.6 to 11 mIU/L), but the exclusion of this group did not change the associations observed (Fig. 2).

Table 3.

Association Between Maternal Thyroid Dysfunction in Early Pregnancy and WPPSI-R and TEACh-5 Scores in Their 5-Year-Old Children

Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Mean Difference
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Mean ScoreChildren (n)Mean ScoreCrudeAdjustedd (95% CI)% Abnormal% AbnormalCrudeAdjustedd (95% CI)
WPPSI-R
 Full IQ1003105.25142104.73−3.74−1.56 (−4.53 to 1.41)15.2519.011.981.34 (0.69–2.61)
 Performance IQ1005104.61142103.99−3.80−1.61 (−5.42 to 2.20)17.0119.011.561.29 (0.68–2.45)
 Verbal IQ1004104.66142104.26−2.90−1.28 (−3.90 to 1.35)13.0517.612.131.52 (0.75–3.10)
TEACh-5
 Overall attention1004−0.001440.03−0.15−0.05 (−0.30 to 0.20)16.0413.891.451.22 (0.64–2.35)
 Sustained attention1001−0.001430.06−0.080.02 (−0.22 to 0.25)16.5811.890.940.73 (0.34–1.58)
 Selective attention1002−0.001440.01−0.11−0.05 (−0.31 to 0.21)16.0715.971.321.25 (0.66–2.35)
Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Mean Difference
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Mean ScoreChildren (n)Mean ScoreCrudeAdjustedd (95% CI)% Abnormal% AbnormalCrudeAdjustedd (95% CI)
WPPSI-R
 Full IQ1003105.25142104.73−3.74−1.56 (−4.53 to 1.41)15.2519.011.981.34 (0.69–2.61)
 Performance IQ1005104.61142103.99−3.80−1.61 (−5.42 to 2.20)17.0119.011.561.29 (0.68–2.45)
 Verbal IQ1004104.66142104.26−2.90−1.28 (−3.90 to 1.35)13.0517.612.131.52 (0.75–3.10)
TEACh-5
 Overall attention1004−0.001440.03−0.15−0.05 (−0.30 to 0.20)16.0413.891.451.22 (0.64–2.35)
 Sustained attention1001−0.001430.06−0.080.02 (−0.22 to 0.25)16.5811.890.940.73 (0.34–1.58)
 Selective attention1002−0.001440.01−0.11−0.05 (−0.31 to 0.21)16.0715.971.321.25 (0.66–2.35)
a

TSH and fT4 within the gestational week–specific reference ranges.

b

TSH and/or fT4 outside the gestational week–specific reference ranges.

c

Abnormal WPPSI-R/TEACh-5 defined by a score below the sample mean minus 1 SD.

d

Adjusted model included maternal IQ, maternal prepregnancy BMI, child’s age at testing, and testing psychologist.

Table 3.

Association Between Maternal Thyroid Dysfunction in Early Pregnancy and WPPSI-R and TEACh-5 Scores in Their 5-Year-Old Children

Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Mean Difference
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Mean ScoreChildren (n)Mean ScoreCrudeAdjustedd (95% CI)% Abnormal% AbnormalCrudeAdjustedd (95% CI)
WPPSI-R
 Full IQ1003105.25142104.73−3.74−1.56 (−4.53 to 1.41)15.2519.011.981.34 (0.69–2.61)
 Performance IQ1005104.61142103.99−3.80−1.61 (−5.42 to 2.20)17.0119.011.561.29 (0.68–2.45)
 Verbal IQ1004104.66142104.26−2.90−1.28 (−3.90 to 1.35)13.0517.612.131.52 (0.75–3.10)
TEACh-5
 Overall attention1004−0.001440.03−0.15−0.05 (−0.30 to 0.20)16.0413.891.451.22 (0.64–2.35)
 Sustained attention1001−0.001430.06−0.080.02 (−0.22 to 0.25)16.5811.890.940.73 (0.34–1.58)
 Selective attention1002−0.001440.01−0.11−0.05 (−0.31 to 0.21)16.0715.971.321.25 (0.66–2.35)
Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Mean Difference
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Mean ScoreChildren (n)Mean ScoreCrudeAdjustedd (95% CI)% Abnormal% AbnormalCrudeAdjustedd (95% CI)
WPPSI-R
 Full IQ1003105.25142104.73−3.74−1.56 (−4.53 to 1.41)15.2519.011.981.34 (0.69–2.61)
 Performance IQ1005104.61142103.99−3.80−1.61 (−5.42 to 2.20)17.0119.011.561.29 (0.68–2.45)
 Verbal IQ1004104.66142104.26−2.90−1.28 (−3.90 to 1.35)13.0517.612.131.52 (0.75–3.10)
TEACh-5
 Overall attention1004−0.001440.03−0.15−0.05 (−0.30 to 0.20)16.0413.891.451.22 (0.64–2.35)
 Sustained attention1001−0.001430.06−0.080.02 (−0.22 to 0.25)16.5811.890.940.73 (0.34–1.58)
 Selective attention1002−0.001440.01−0.11−0.05 (−0.31 to 0.21)16.0715.971.321.25 (0.66–2.35)
a

TSH and fT4 within the gestational week–specific reference ranges.

b

TSH and/or fT4 outside the gestational week–specific reference ranges.

c

Abnormal WPPSI-R/TEACh-5 defined by a score below the sample mean minus 1 SD.

d

Adjusted model included maternal IQ, maternal prepregnancy BMI, child’s age at testing, and testing psychologist.

Adjusted mean difference with 95% confidence interval in child verbal IQ by maternal TSH (top) and fT4 (bottom) measured in an early pregnancy blood sample. Reference group was maternal TSH in the range from 0.1 to 2.49 mIU/L (top) and maternal fT4 in the range from 12.0 to 18.99 (bottom). The adjusted model included maternal IQ, maternal prepregnancy BMI, child’s age at testing, and testing psychologist. In the bottom panel, all women with fT4 < 10 pmol/L (n = 4) had TSH ≥ 10 mIU/L. Among women with fT4 in the range from 10 to 12 pmol/L, 11 women had overt hypothyroidism; the exclusion of this group revealed the following associations: fT4 10.0 to 10.99 pmol/L (n = 14): adjusted mean difference, 1.14 (95% CI, −4.91 to 7.18), fT4 11.0 to 11.99 pmol/L (n = 62): adjusted mean difference, 1.10 (95% CI, −2.17 to 4.37).
Figure 2.

Adjusted mean difference with 95% confidence interval in child verbal IQ by maternal TSH (top) and fT4 (bottom) measured in an early pregnancy blood sample. Reference group was maternal TSH in the range from 0.1 to 2.49 mIU/L (top) and maternal fT4 in the range from 12.0 to 18.99 (bottom). The adjusted model included maternal IQ, maternal prepregnancy BMI, child’s age at testing, and testing psychologist. In the bottom panel, all women with fT4 < 10 pmol/L (n = 4) had TSH ≥ 10 mIU/L. Among women with fT4 in the range from 10 to 12 pmol/L, 11 women had overt hypothyroidism; the exclusion of this group revealed the following associations: fT4 10.0 to 10.99 pmol/L (n = 14): adjusted mean difference, 1.14 (95% CI, −4.91 to 7.18), fT4 11.0 to 11.99 pmol/L (n = 62): adjusted mean difference, 1.10 (95% CI, −2.17 to 4.37).

Other measures of IQ showed similar trends though nonsignificant [adjusted mean difference in full IQ: TSH ≥ 10 mIU/l, −8.2 (95% CI, −19.2 to 2.8), fT4 < 10 pmol/L, −10.6 (95% CI, −24.3 to 3.04); performance IQ: TSH ≥ 10 mIU/L, −5.9 (95% CI, −21.8 to 9.9), fT4 < 10 pmol/L, −5.3 (95% CI, −26.4 to 15.8)]. The association between maternal thyroid function and child verbal IQ was also evaluated by using restricted cubic splines (Supplemental Fig. 1). This analysis showed a significant association with TSH, which was robust for a change in the number and location of knots, whereas the model of fT4 was nonsignificant.

Child attention was evaluated from overall, sustained, and selective attention, with lower scores indicating poorer performance, and showed no association (Table 3).

Child motor function was evaluated only in a subgroup of participants (n = 487). The total score was a median of 7.5 both in children born to mothers with thyroid dysfunction (n = 60) and in nonexposed children (n = 427); adjusted exponentiated β was 1.07 (95% CI, 0.75 to 1.54). However, 16.7% of children born to mothers with thyroid dysfunction were classified as having an abnormal score compared with 9.8% among nonexposed children: Crude odds ratio (OR) was 6.21 (95% CI, 2.41 to 16.0), and adjusted OR was 5.82 (95% CI, 2.33 to 14.6). Most exposed children with abnormal score had been exposed to maternal hypothyroxinemia.

Child executive function and behavior were evaluated from parent and teacher reports of the BRIEF and the SDQ questionnaires, with higher scores indicating more difficulties (Tables 4 and 5). No association was observed with parent reports. On the other hand, BRIEF and SDQ showed more difficulties in children born to mothers with thyroid dysfunction when evaluated by their teacher. Evaluation of exposed cases with abnormal score indicated that the associations were predominated by exposure to maternal hypothyroxinemia, which showed associations with teacher-reported abnormal BRIEF scores [behavioral regulation index: adjusted OR, 3.43 (95% CI, 1.44 to 8.18); metacognition index: adjusted OR, 4.70 (95% CI, 2.05 to 10.7)], and SDQ scores [internalizing problems: adjusted OR, 2.36 (95% CI, 0.84 to 6.65); externalizing problems: adjusted OR, 4.33 (95% CI, 1.69 to 11.1)]. Stratification by child’s sex revealed differences in the stratum-specific estimates for internalizing problems in the SDQ teacher report [adjusted ORs for abnormal score, 6.86 (95% CI, 2.53 to 18.61) in girls and 1.33 (95% CI, 0.51 to 3.47) in boys], with significant deviation from multiplicative and additive interaction (Supplemental Table 1). Significant interaction was not observed for other outcomes.

Table 4.

Association Between Maternal Thyroid Dysfunction in Early Pregnancy and BRIEF Scores in Their 5-Year-Old Children

Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Mean Difference
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Mean ScoreChildren (n)Mean ScoreCrudeAdjustedd (95% CI)% Abnormal% AbnormalCrude Adjustedd (95% CI)
Parent report
 General executive composite100650.0714449.560.840.21 (−2.51 to 2.93)16.1015.971.371.29 (0.67–2.49)
 Behavioral regulation index100650.1014449.560.900.31 (−2.15 to 2.78)15.5112.501.211.07 (0.53–2.15)
 Metacognition index1,00650.0714449.660.740.13 (−2.69 to 2.95)15.1118.061.511.39 (0.73–2.66)
Teacher report
 General executive composite87949.8312751.224.764.13 (1.01–7.25)15.5919.693.092.76 (1.48–5.16)
 Behavioral regulation index88249.8312851.304.313.85 (0.86–6.84)14.9722.663.132.88 (1.57–5.27)
 Metacognition index87949.8812751.064.543.89 (0.76–7.02)15.2418.112.722.38 (1.24–4.58)
Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Mean Difference
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Mean ScoreChildren (n)Mean ScoreCrudeAdjustedd (95% CI)% Abnormal% AbnormalCrude Adjustedd (95% CI)
Parent report
 General executive composite100650.0714449.560.840.21 (−2.51 to 2.93)16.1015.971.371.29 (0.67–2.49)
 Behavioral regulation index100650.1014449.560.900.31 (−2.15 to 2.78)15.5112.501.211.07 (0.53–2.15)
 Metacognition index1,00650.0714449.660.740.13 (−2.69 to 2.95)15.1118.061.511.39 (0.73–2.66)
Teacher report
 General executive composite87949.8312751.224.764.13 (1.01–7.25)15.5919.693.092.76 (1.48–5.16)
 Behavioral regulation index88249.8312851.304.313.85 (0.86–6.84)14.9722.663.132.88 (1.57–5.27)
 Metacognition index87949.8812751.064.543.89 (0.76–7.02)15.2418.112.722.38 (1.24–4.58)
a

TSH and fT4 within the gestational week–specific reference ranges.

b

TSH and/or fT4 outside the gestational week–specific reference ranges.

c

Abnormal BRIEF defined by a score above the sample mean plus 1 SD.

d

Adjusted model included maternal IQ and maternal prepregnancy BMI.

Table 4.

Association Between Maternal Thyroid Dysfunction in Early Pregnancy and BRIEF Scores in Their 5-Year-Old Children

Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Mean Difference
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Mean ScoreChildren (n)Mean ScoreCrudeAdjustedd (95% CI)% Abnormal% AbnormalCrude Adjustedd (95% CI)
Parent report
 General executive composite100650.0714449.560.840.21 (−2.51 to 2.93)16.1015.971.371.29 (0.67–2.49)
 Behavioral regulation index100650.1014449.560.900.31 (−2.15 to 2.78)15.5112.501.211.07 (0.53–2.15)
 Metacognition index1,00650.0714449.660.740.13 (−2.69 to 2.95)15.1118.061.511.39 (0.73–2.66)
Teacher report
 General executive composite87949.8312751.224.764.13 (1.01–7.25)15.5919.693.092.76 (1.48–5.16)
 Behavioral regulation index88249.8312851.304.313.85 (0.86–6.84)14.9722.663.132.88 (1.57–5.27)
 Metacognition index87949.8812751.064.543.89 (0.76–7.02)15.2418.112.722.38 (1.24–4.58)
Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Mean Difference
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Mean ScoreChildren (n)Mean ScoreCrudeAdjustedd (95% CI)% Abnormal% AbnormalCrude Adjustedd (95% CI)
Parent report
 General executive composite100650.0714449.560.840.21 (−2.51 to 2.93)16.1015.971.371.29 (0.67–2.49)
 Behavioral regulation index100650.1014449.560.900.31 (−2.15 to 2.78)15.5112.501.211.07 (0.53–2.15)
 Metacognition index1,00650.0714449.660.740.13 (−2.69 to 2.95)15.1118.061.511.39 (0.73–2.66)
Teacher report
 General executive composite87949.8312751.224.764.13 (1.01–7.25)15.5919.693.092.76 (1.48–5.16)
 Behavioral regulation index88249.8312851.304.313.85 (0.86–6.84)14.9722.663.132.88 (1.57–5.27)
 Metacognition index87949.8812751.064.543.89 (0.76–7.02)15.2418.112.722.38 (1.24–4.58)
a

TSH and fT4 within the gestational week–specific reference ranges.

b

TSH and/or fT4 outside the gestational week–specific reference ranges.

c

Abnormal BRIEF defined by a score above the sample mean plus 1 SD.

d

Adjusted model included maternal IQ and maternal prepregnancy BMI.

Table 5.

Association Between Maternal Thyroid Dysfunction in Early Pregnancy and SDQ Scores in Their 5-Year-Old Children

Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Exponentiated β
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Median ScoreChildren (n)Median ScoreCrude Adjustedd (95% CI)% Abnormal% AbnormalCrudeAdjustedd (95% CI)
Parent report
 Total difficulties score1001614561.061.03 (0.86–1.23)9.598.970.950.90 (0.36–2.26)
 Internalizing problems1000214521.161.16 (0.95–1.42)6.4011.031.571.50 (0.67–3.37)
 Externalizing problems1001414441.030.99 (0.83–1.19)11.7911.111.381.29 (0.59–2.82)
Teacher report
 Total difficulties score884412851.451.40 (1.09–1.81)8.9412.503.513.07 (1.48–6.34)
 Internalizing problems884112821.561.50 (1.14–1.96)9.1614.062.942.66 (1.32–5.36)
 Externalizing problems884212821.471.42 (1.09–1.85)9.9512.502.692.42 (1.16–5.04)
Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Exponentiated β
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Median ScoreChildren (n)Median ScoreCrude Adjustedd (95% CI)% Abnormal% AbnormalCrudeAdjustedd (95% CI)
Parent report
 Total difficulties score1001614561.061.03 (0.86–1.23)9.598.970.950.90 (0.36–2.26)
 Internalizing problems1000214521.161.16 (0.95–1.42)6.4011.031.571.50 (0.67–3.37)
 Externalizing problems1001414441.030.99 (0.83–1.19)11.7911.111.381.29 (0.59–2.82)
Teacher report
 Total difficulties score884412851.451.40 (1.09–1.81)8.9412.503.513.07 (1.48–6.34)
 Internalizing problems884112821.561.50 (1.14–1.96)9.1614.062.942.66 (1.32–5.36)
 Externalizing problems884212821.471.42 (1.09–1.85)9.9512.502.692.42 (1.16–5.04)
a

TSH and fT4 within the gestational week–specific reference ranges.

b

TSH and/or fT4 outside the gestational week–specific reference ranges.

c

Abnormal SDQ defined by sex-specific cutoffs previously established in Danish 5-year-old children (17).

d

Adjusted model included maternal IQ and maternal prepregnancy BMI.

Table 5.

Association Between Maternal Thyroid Dysfunction in Early Pregnancy and SDQ Scores in Their 5-Year-Old Children

Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Exponentiated β
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Median ScoreChildren (n)Median ScoreCrude Adjustedd (95% CI)% Abnormal% AbnormalCrudeAdjustedd (95% CI)
Parent report
 Total difficulties score1001614561.061.03 (0.86–1.23)9.598.970.950.90 (0.36–2.26)
 Internalizing problems1000214521.161.16 (0.95–1.42)6.4011.031.571.50 (0.67–3.37)
 Externalizing problems1001414441.030.99 (0.83–1.19)11.7911.111.381.29 (0.59–2.82)
Teacher report
 Total difficulties score884412851.451.40 (1.09–1.81)8.9412.503.513.07 (1.48–6.34)
 Internalizing problems884112821.561.50 (1.14–1.96)9.1614.062.942.66 (1.32–5.36)
 Externalizing problems884212821.471.42 (1.09–1.85)9.9512.502.692.42 (1.16–5.04)
Variable No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Exponentiated β
No Thyroid Dysfunctiona
Thyroid Dysfunctionb
Odds Ratio for Abnormal Scorec
Children (n)Median ScoreChildren (n)Median ScoreCrude Adjustedd (95% CI)% Abnormal% AbnormalCrudeAdjustedd (95% CI)
Parent report
 Total difficulties score1001614561.061.03 (0.86–1.23)9.598.970.950.90 (0.36–2.26)
 Internalizing problems1000214521.161.16 (0.95–1.42)6.4011.031.571.50 (0.67–3.37)
 Externalizing problems1001414441.030.99 (0.83–1.19)11.7911.111.381.29 (0.59–2.82)
Teacher report
 Total difficulties score884412851.451.40 (1.09–1.81)8.9412.503.513.07 (1.48–6.34)
 Internalizing problems884112821.561.50 (1.14–1.96)9.1614.062.942.66 (1.32–5.36)
 Externalizing problems884212821.471.42 (1.09–1.85)9.9512.502.692.42 (1.16–5.04)
a

TSH and fT4 within the gestational week–specific reference ranges.

b

TSH and/or fT4 outside the gestational week–specific reference ranges.

c

Abnormal SDQ defined by sex-specific cutoffs previously established in Danish 5-year-old children (17).

d

Adjusted model included maternal IQ and maternal prepregnancy BMI.

Discussion

This nationwide cohort study combined neuropsychological test results from a large group of children with the measurement of maternal thyroid function in stored biobank sera from early pregnancy. Results corroborate and extend the hypothesis of adverse neuropsychological function in children prenatally exposed to maternal thyroid function abnormalities. Interestingly, associations differed in magnitude by subtype of maternal thyroid dysfunction and areas of child neuropsychological function.

An individual’s ability to acquire and apply knowledge and skills can be assessed by the use of verbal and nonverbal intelligence tests. IQ is a frequently used standardized method for measuring intellectual ability, and numerous association studies have been conducted on genetic and environmental risk factors. We evaluated a spectrum of abnormalities in maternal thyroid function and different levels of TSH and fT4 and observed a distinct association with lack of maternal thyroid hormones. In fact, verbal IQ was lower in children born to mothers whose thyroid function testing indicated marked hypothyroidism in early pregnancy. Cognitive development after in utero exposure to maternal hypothyroidism has been considered for decades, and the scientific interest has extended beyond the consequences of overt hypothyroidism. Thus, the potential adverse effect of smaller aberrations in maternal function has been a major topic of debate (4). Studies within this field not only differ in regard to definition and type of maternal thyroid dysfunction but also show considerable disparities concerning the age of the child at testing and type of neurocognitive outcome. A major study published in 1999 by Haddow et al. (18) showed that 48 children born to mothers with undiagnosed hypothyroidism (defined by TSH >98th percentile; range, ∼5 to 90 mIU/L) in pregnancy had a lower IQ at age 7 to 9 years compared with 124 controls and 14 children whose mother had hypothyroidism but received treatment in the pregnancy. Similar to our study, this study (18) evaluated full, performance, and verbal IQ from the Wechsler intelligence scale and found lower performance with all three measurements.

We can only speculate on underlying developmental abnormalities in children with low verbal IQ. Evidence from experimental studies has shown developmental effects of maternal hypothyroidism on the fetal brain and involvement of different areas of the brain (19, 20). Abnormalities in the development of hippocampus have been described both in rats (21) and in human offspring (22) exposed to maternal hypothyroidism, and children with abnormal hippocampal development had impaired memory (22). Interestingly, the size of the hippocampus correlated with verbal, but not performance, IQ in male children (23).

We also observed an association between low maternal fT4 and child verbal IQ, and all cases with maternal fT4 <10 pmol/L in our population had high TSH and were classified as having overt hypothyroidism. The association with fT4 showed a nonsignificant U-shaped trend, which was not robust in our sample. Results from the Generation R study showed that both maternal high and low fT4 were associated with lower nonverbal IQ and altered gray matter and cortex volume at 6 to 8 years of age (24). On the other hand, this study showed no association with maternal TSH (24). Numerous studies have examined the association between subclinical hypothyroidism or hypothyroxinemia and child IQ (20, 25). However, results of randomized controlled trials have not shown improved cognitive outcomes after treatment of such abnormalities (26, 27). Notably, we found that children whose mothers had early pregnancy TSH in the range from 2.5 to 5 mIU/L and from 5 to 10 mIU/L did not have lower IQ when compared with those whose maternal TSH was <2.5 mIU/L. Clinical guidelines on the management of thyroid disease in pregnant women have recently revised the recommendation on TSH upper limit in the first trimester of pregnancy, raising it from 2.5 to 4.0 mIU/L (3). Our results support this change in the upper limit of TSH.

We had no information on thyroid autoantibodies, and we could not directly evaluate the impact of thyroid autoimmunity per se. However, individuals with elevated TSH are in general more likely to have thyroid peroxidase and/or thyroglobulin autoantibodies (28), and the observation that children whose mother had TSH in the range from 5 to 10 mIU/L did not have lower IQ may argue against thyroid autoimmunity as a major determinant of the associations observed.

We found an association between maternal thyroid function and child motor function, executive function, and behavior at 5 years of age, and, in contrast to IQ, these associations were dominated by exposure to isolated changes in maternal fT4. Previous studies have shown an association between maternal hypothyroxinemia and delayed child motor function at 2.5 years of age or earlier (29–32). For outcomes of executive function and behavior, our findings were confined to teacher reports. A recent study from the Netherlands (33) evaluated the association between maternal hypothyroxinemia and outcomes of SDQ at 5 to 6 years of age and found no association with parent reports but did find an association with teacher-reported symptoms of hyperactivity/inattention. Similarly, a study from the Generation R cohort observed an association between maternal hypothyroxinemia and symptoms of attention-deficit/hyperactivity disorder (34), whereas another study within the same cohort reported an association with markers of thyroid autoimmunity (35). Our finding of an association between maternal thyroid function and internalizing problems in the child should be a topic for future studies, including the interaction with child’s sex.

A strength of our study was the measurement of maternal thyroid function in stored biobank sera for the detection of undiagnosed thyroid disease in early pregnancy. Assessment of maternal thyroid function in our study was based on a single measurement in early pregnancy and may not reflect maternal thyroid status throughout the pregnancy. Still, major deviations were likely to be detected and correct (36). We were able to identify women currently treated for thyroid disease from self-report but had no information on redeemed prescriptions of drugs. The exclusion of women (n = 4) who reported current treatment with thyroid hormone did not change results. Mother-child pairs were selected from a nationwide cohort, and all analyses were weighted by sampling fraction to account for the slightly skewed selection, as evaluated from maternal alcohol intake. Participants with results of both maternal thyroid function testing and child neuropsychological testing were similar to all women selected for the follow-up study. Still, the number of participants was limited considering the evaluation of subtypes of maternal thyroid function.

Neuropsychological testing was performed by trained psychologists, and the children were 5 years of age. Yet, we acknowledge that the stability of cognitive test scores may be low even at this age (37), and it is unknown whether the changes will fade or persist and affect long-term outcomes. We had information on several potential confounders, including maternal IQ, but unmeasured or residual confounding may persist. We considered maternal IQ a potential confounder because it associates with child IQ and also potentially with our exposure variable via socioeconomic status and therefore different environmental exposures, which are known risk factors for thyroid disease. We have noticed that most previous investigations did not include information on maternal IQ, and further studies considering maternal IQ are warranted. We had no information on paternal IQ, which may be associated with the outcomes under study (38, 39). It remains uncertain whether measurement of paternal intelligence would be associated with our exposure, and a study on an alternative fetal exposure showed that paternal IQ was not significant after adjustment for maternal IQ.

Conclusion

Measurement of maternal thyroid function in biobank sera from pregnant women in a Danish nationwide birth cohort showed that marked maternal hypothyroidism in early pregnancy was associated with lower child verbal IQ, whereas no association was observed with smaller abnormalities in maternal thyroid function. On the other hand, isolated deviations in maternal fT4 was associated with child motor function, executive function, and problem behavior. Further investigations are needed to elucidate whether the detection and treatment of maternal thyroid abnormalities will improve child outcomes.

Abbreviations:

     
  • BMI

    body mass index

  •  
  • BRIEF

    Behavior Rating Inventory of Executive Function

  •  
  • CI

    confidence interval

  •  
  • DNBC

    Danish National Birth Cohort

  •  
  • fT4

    free thyroxine

  •  
  • IQ

    intelligence quotient

  •  
  • LDPS

    Lifestyle During Pregnancy Study

  •  
  • MABC

    Movement Assessment Battery for Children

  •  
  • OR

    odds ratio

  •  
  • SD

    standard deviation

  •  
  • SDQ

    Strengths and Difficulties Questionnaire

  •  
  • TEACh-5

    Test of Everyday Attention for Children at Five

  •  
  • TSH

    thyroid-stimulating hormone

  •  
  • WPPSI-R

    Wechsler Primary and Preschool Scale of Intelligence-Revised.

Acknowledgments

We acknowledge Professor Peter Laurberg, Department of Endocrinology, Aalborg University Hospital, Denmark, who died on 20 June 2016. Professor Laurberg conceptualized and initiated the study, participated in the design, and was responsible for the biochemical analyses.

Financial Support: This work was supported by the Obel Family Foundation. This research has been conducted using the Danish National Biobank resource. The Danish National Biobank is supported by the Novo Nordisk Foundation. The Danish National Research Foundation has established the Danish Epidemiology Science Centre, which initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this foundation. Additional support for the Danish National Birth Cohort is obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. Z.L. was supported by the National Institutes of Health/National Institute of Environmental Health Sciences Pathway to Independence Award (K99ES026729).

Disclosure Summary: The authors have nothing to disclose.

References

1.

Bernal
J
.
Thyroid hormone regulated genes in cerebral cortex development
.
J Endocrinol
.
2017
;
232
(
2
):
R83
R97
.

2.

Andersen
SL
,
Carlé
A
,
Karmisholt
J
,
Pedersen
IB
,
Andersen
S
.
Mechanisms in endocrinology: Neurodevelopmental disorders in children born to mothers with thyroid dysfunction: evidence of fetal programming
?
Eur J Endocrinol
.
2017
;
177
(
1
):
R27
R36
.

3.

Alexander
EK
,
Pearce
EN
,
Brent
GA
,
Brown
RS
,
Chen
H
,
Dosiou
C
,
Grobman
WA
,
Laurberg
P
,
Lazarus
JH
,
Mandel
SJ
,
Peeters
RP
,
Sullivan
S
.
2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum
.
Thyroid
.
2017
;
27
(
3
):
315
389
.

4.

Laurberg
P
,
Andersen
SL
,
Pedersen
IB
,
Andersen
S
,
Carlé
A
.
Screening for overt thyroid disease in early pregnancy may be preferable to searching for small aberrations in thyroid function tests
.
Clin Endocrinol (Oxf)
.
2013
;
79
(
3
):
297
304
.

5.

Olsen
J
,
Melbye
M
,
Olsen
SF
,
Sørensen
TI
,
Aaby
P
,
Andersen
AM
,
Taxbøl
D
,
Hansen
KD
,
Juhl
M
,
Schow
TB
,
Sørensen
HT
,
Andresen
J
,
Mortensen
EL
,
Olesen
AW
,
Søndergaard
C
.
The Danish National Birth Cohort—its background, structure and aim
.
Scand J Public Health
.
2001
;
29
(
4
):
300
307
.

6.

Kesmodel
US
,
Underbjerg
M
,
Kilburn
TR
,
Bakketeig
L
,
Mortensen
EL
,
Landrø
NI
,
Schendel
D
,
Bertrand
J
,
Grove
J
,
Ebrahim
S
,
Thorsen
P
.
Lifestyle during pregnancy: neurodevelopmental effects at 5 years of age. The design and implementation of a prospective follow-up study
.
Scand J Public Health
.
2010
;
38
(
2
):
208
219
.

7.

Laurberg
P
,
Andersen
SL
,
Hindersson
P
,
Nohr
EA
,
Olsen
J
.
Dynamics and predictors of serum TSH and fT4 reference limits in early pregnancy: a study within the Danish National Birth Cohort
.
J Clin Endocrinol Metab
.
2016
;
101
(
6
):
2484
2492
.

8.

Andersen
SL
,
Olsen
J
.
Early pregnancy thyroid function test abnormalities in biobank sera from women clinically diagnosed with thyroid dysfunction before or after pregnancy
.
Thyroid
.
2017
;
27
(
3
):
451
459
.

9.

Kesmodel
US
,
Eriksen
HL
,
Underbjerg
M
,
Kilburn
TR
,
Støvring
H
,
Wimberley
T
,
Mortensen
EL
.
The effect of alcohol binge drinking in early pregnancy on general intelligence in children
.
BJOG
.
2012
;
119
(
10
):
1222
1231
.

10.

Underbjerg
M
,
George
MS
,
Thorsen
P
,
Kesmodel
US
,
Mortensen
EL
,
Manly
T
.
Separable sustained and selective attention factors are apparent in 5-year-old children
.
PLoS One
.
2013
;
8
(
12
):
e82843
.

11.

Nordbye-Nielsen
K
,
Kesmodel
US
.
Parental questionnaire as a screening instrument for motor function at age five
.
Dan Med J
.
2014
;
61
(
12
):
A4976
.

12.

Baron
IS
.
Behavior rating inventory of executive function
[published correction appears in Child Neuropsychol. 2016;22(6):761].
Child Neuropsychol
.
2000
;
6
(
3
):
235
238
.

13.

Kesmodel
US
,
Bertrand
J
,
Støvring
H
,
Skarpness
B
,
Denny
CH
,
Mortensen
EL
;
Lifestyle During Pregnancy Study Group
.
The effect of different alcohol drinking patterns in early to mid pregnancy on the child’s intelligence, attention, and executive function
.
BJOG
.
2012
;
119
(
10
):
1180
1190
.

14.

Goodman
R
.
The strengths and difficulties questionnaire: a research note
.
J Child Psychol Psychiatry
.
1997
;
38
(
5
):
581
586
.

15.

Niclasen
J
,
Skovgaard
AM
,
Andersen
AM
,
Sømhovd
MJ
,
Obel
C
.
A confirmatory approach to examining the factor structure of the Strengths and Difficulties Questionnaire (SDQ): a large scale cohort study
.
J Abnorm Child Psychol
.
2013
;
41
(
3
):
355
365
.

16.

Knudsen
LB
,
Olsen
J
.
The Danish Medical Birth Registry
.
Dan Med Bull
.
1998
;
45
(
3
):
320
323
.

17.

Niclasen J. SDQ cut off scores for danish 5-7-year-olds. http://www.sdqinfo.com/norms/SDQ_Danish_cut_off_scores_5_7_year_olds.pdf. Accessed 23 June 2017.

18.

Haddow
JE
,
Palomaki
GE
,
Allan
WC
,
Williams
JR
,
Knight
GJ
,
Gagnon
J
,
O’Heir
CE
,
Mitchell
ML
,
Hermos
RJ
,
Waisbren
SE
,
Faix
JD
,
Klein
RZ
.
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
.
N Engl J Med
.
1999
;
341
(
8
):
549
555
.

19.

de Escobar
GM
,
Obregón
MJ
,
del Rey
FE
.
Maternal thyroid hormones early in pregnancy and fetal brain development
.
Best Pract Res Clin Endocrinol Metab
.
2004
;
18
(
2
):
225
248
.

20.

Moog
NK
,
Entringer
S
,
Heim
C
,
Wadhwa
PD
,
Kathmann
N
,
Buss
C
.
Influence of maternal thyroid hormones during gestation on fetal brain development
.
Neuroscience
.
2017
;
342
:
68
100
.

21.

Ausó
E
,
Lavado-Autric
R
,
Cuevas
E
,
Del Rey
FE
,
Morreale De Escobar
G
,
Berbel
P
.
A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration
.
Endocrinology
.
2004
;
145
(
9
):
4037
4047
.

22.

Willoughby
KA
,
McAndrews
MP
,
Rovet
JF
.
Effects of maternal hypothyroidism on offspring hippocampus and memory
.
Thyroid
.
2014
;
24
(
3
):
576
584
.

23.

Schumann
CM
,
Hamstra
J
,
Goodlin-Jones
BL
,
Kwon
H
,
Reiss
AL
,
Amaral
DG
.
Hippocampal size positively correlates with verbal IQ in male children
.
Hippocampus
.
2007
;
17
(
6
):
486
493
.

24.

Korevaar
TI
,
Muetzel
R
,
Medici
M
,
Chaker
L
,
Jaddoe
VW
,
de Rijke
YB
,
Steegers
EA
,
Visser
TJ
,
White
T
,
Tiemeier
H
,
Peeters
RP
.
Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study
.
Lancet Diabetes Endocrinol
.
2016
;
4
(
1
):
35
43
.

25.

Henrichs
J
,
Ghassabian
A
,
Peeters
RP
,
Tiemeier
H
.
Maternal hypothyroxinemia and effects on cognitive functioning in childhood: how and why
?
Clin Endocrinol (Oxf)
.
2013
;
79
(
2
):
152
162
.

26.

Lazarus
JH
,
Bestwick
JP
,
Channon
S
,
Paradice
R
,
Maina
A
,
Rees
R
,
Chiusano
E
,
John
R
,
Guaraldo
V
,
George
LM
,
Perona
M
,
Dall’Amico
D
,
Parkes
AB
,
Joomun
M
,
Wald
NJ
.
Antenatal thyroid screening and childhood cognitive function
.
N Engl J Med
.
2012
;
366
(
6
):
493
501
.

27.

Casey
BM
,
Thom
EA
,
Peaceman
AM
,
Varner
MW
,
Sorokin
Y
,
Hirtz
DG
,
Reddy
UM
,
Wapner
RJ
,
Thorp
JM
, Jr
,
Saade
G
,
Tita
AT
,
Rouse
DJ
,
Sibai
B
,
Iams
JD
,
Mercer
BM
,
Tolosa
J
,
Caritis
SN
,
VanDorsten
JP
;
Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network
.
Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy
.
N Engl J Med
.
2017
;
376
(
9
):
815
825
.

28.

Pedersen
IB
,
Knudsen
N
,
Jørgensen
T
,
Perrild
H
,
Ovesen
L
,
Laurberg
P
.
Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency
.
Clin Endocrinol (Oxf)
.
2003
;
58
(
1
):
36
42
.

29.

Pop
VJ
,
Kuijpens
JL
,
van Baar
AL
,
Verkerk
G
,
van Son
MM
,
de Vijlder
JJ
,
Vulsma
T
,
Wiersinga
WM
,
Drexhage
HA
,
Vader
HL
.
Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy
.
Clin Endocrinol (Oxf)
.
1999
;
50
(
2
):
149
155
.

30.

Pop
VJ
,
Brouwers
EP
,
Vader
HL
,
Vulsma
T
,
van Baar
AL
,
de Vijlder
JJ
.
Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study
.
Clin Endocrinol (Oxf)
.
2003
;
59
(
3
):
282
288
.

31.

Craig
WY
,
Allan
WC
,
Kloza
EM
,
Pulkkinen
AJ
,
Waisbren
S
,
Spratt
DI
,
Palomaki
GE
,
Neveux
LM
,
Haddow
JE
.
Mid-gestational maternal free thyroxine concentration and offspring neurocognitive development at age two years
.
J Clin Endocrinol Metab
.
2012
;
97
(
1
):
E22
E28
.

32.

Julvez
J
,
Alvarez-Pedrerol
M
,
Rebagliato
M
,
Murcia
M
,
Forns
J
,
Garcia-Esteban
R
,
Lertxundi
N
,
Espada
M
,
Tardón
A
,
Riaño Galán
I
,
Sunyer
J
.
Thyroxine levels during pregnancy in healthy women and early child neurodevelopment
.
Epidemiology
.
2013
;
24
(
1
):
150
157
.

33.

Oostenbroek
MHW
,
Kersten
RHJ
,
Tros
B
,
Kunst
AE
,
Vrijkotte
TGM
,
Finken
MJJ
.
Maternal hypothyroxinaemia in early pregnancy and problem behavior in 5-year-old offspring
.
Psychoneuroendocrinology
.
2017
;
81
:
29
35
.

34.

Modesto
T
,
Tiemeier
H
,
Peeters
RP
,
Jaddoe
VW
,
Hofman
A
,
Verhulst
FC
,
Ghassabian
A
.
Maternal mild thyroid hormone insufficiency in early pregnancy and attention-deficit/hyperactivity disorder symptoms in children
.
JAMA Pediatr
.
2015
;
169
(
9
):
838
845
.

35.

Ghassabian
A
,
Bongers-Schokking
JJ
,
de Rijke
YB
,
van Mil
N
,
Jaddoe
VW
,
de Muinck Keizer-Schrama
SM
,
Hooijkaas
H
,
Hofman
A
,
Visser
W
,
Roman
GC
,
Visser
TJ
,
Verhulst
FC
,
Tiemeier
H
.
Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study
.
Thyroid
.
2012
;
22
(
2
):
178
186
.

36.

Andersen
S
,
Bruun
NH
,
Pedersen
KM
,
Laurberg
P
.
Biologic variation is important for interpretation of thyroid function tests
.
Thyroid
.
2003
;
13
(
11
):
1069
1078
.

37.

Schuerger
JM
,
Witt
AC
.
The temporal stability of individually tested intelligence
.
J Clin Psychol
.
1989
;
45
(
2
):
294
302
.

38.

Whitley
E
,
Gale
CR
,
Deary
IJ
,
Kivimaki
M
,
Batty
GD
.
Association of maternal and paternal IQ with offspring conduct, emotional, and attention problem scores. Transgenerational evidence from the 1958 British Birth Cohort Study
.
Arch Gen Psychiatry
.
2011
;
68
(
10
):
1032
1038
.

39.

Meador
KJ
,
Baker
GA
,
Browning
N
,
Clayton-Smith
J
,
Cohen
MJ
,
Kalayjian
LA
,
Kanner
A
,
Liporace
JD
,
Pennell
PB
,
Privitera
M
,
Loring
DW
.
Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure
.
Epilepsy Behav
.
2011
;
21
(
2
):
147
152
.

Supplementary data